Literature DB >> 24321985

Ensuring participant safety and trial integrity with clinical trials oversight.

Catherine Godfrey1, Manizhe Payton, Sybil Tasker, Scott Proestel, Jeffrey T Schouten.   

Abstract

Clinical trial oversight is a critical element that ensures the protection of research participants and integrity of the data collected. The trial sponsor, a local Institutional Review Board, and independent monitoring committees all contribute with complementary but overlapping responsibilities. Consistency among these groups is essential for the smooth conduct of a clinical trial but may be challenging in resource-limited settings (RLS). Capacity building and training for RLS may improve clinical trials oversight and ultimately medical management. In this article, we review the components necessary for optimal clinical trial oversight and the issues that arise in the RLS, with some suggested strategies for improvement.

Entities:  

Mesh:

Year:  2014        PMID: 24321985      PMCID: PMC3916962          DOI: 10.1097/QAI.0000000000000041

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

1.  Mapping African ethical review committee activity onto capacity needs: the MARC initiative and HRWeb's interactive database of RECs in Africa.

Authors:  Carel IJsselmuiden; Debbie Marais; Douglas Wassenaar; Boitumelo Mokgatla-Moipolai
Journal:  Dev World Bioeth       Date:  2012-04-18       Impact factor: 2.294

2.  The WHO/PEPFAR collaboration to prepare an operations manual for HIV prevention, care, and treatment at primary health centers in high-prevalence, resource-constrained settings: defining laboratory services.

Authors:  Thomas Spira; Mary Lou Lindegren; Robert Ferris; Vincent Habiyambere; Tedd Ellerbrock
Journal:  Am J Clin Pathol       Date:  2009-06       Impact factor: 2.493

3.  Ethical and scientific implications of the globalization of clinical research.

Authors:  Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

4.  Monitoring the quality of conduct of clinical trials: a survey of current practices.

Authors:  Briggs W Morrison; Chrissy J Cochran; Jennifer Giangrande White; Joan Harley; Cynthia F Kleppinger; An Liu; Jules T Mitchel; David F Nickerson; Cynthia R Zacharias; Judith M Kramer; James D Neaton
Journal:  Clin Trials       Date:  2011-06       Impact factor: 2.486

5.  Strengthening laboratory systems in resource-limited settings.

Authors:  Stuart S Olmsted; Melinda Moore; Robin C Meili; Herbert C Duber; Jeffrey Wasserman; Preethi Sama; Ben Mundell; Lee H Hilborne
Journal:  Am J Clin Pathol       Date:  2010-09       Impact factor: 2.493

6.  Ensuring trial validity by data quality assurance and diversification of monitoring methods.

Authors:  Colin Baigent; Frank E Harrell; Marc Buyse; Jonathan R Emberson; Douglas G Altman
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

7.  Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials.

Authors:  Oana Brosteanu; Peggy Houben; Kristina Ihrig; Christian Ohmann; Ursula Paulus; Beate Pfistner; Gabriele Schwarz; Anke Strenge-Hesse; Ulrike Zettelmeyer
Journal:  Clin Trials       Date:  2009-11-06       Impact factor: 2.486

8.  Participants' perspectives on safety monitoring in clinical trials.

Authors:  Kathryn E Flynn; Judith M Kramer; Carrie B Dombeck; Kevin P Weinfurt
Journal:  Clin Trials       Date:  2013-05-03       Impact factor: 2.486

9.  Ethics committees in India: Facing the challenges!

Authors:  Rashmi Kadam; Shashikant Karandikar
Journal:  Perspect Clin Res       Date:  2012-04

10.  The future of monitoring in clinical research - a holistic approach: linking risk-based monitoring with quality management principles.

Authors:  Eva B Ansmann; Arthur Hecht; Doris K Henn; Sabine Leptien; Hans Günther Stelzer
Journal:  Ger Med Sci       Date:  2013-02-04
View more
  1 in total

1.  Participants' awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey.

Authors:  Gerardo González-Saldivar; René Rodríguez-Gutiérrez; Jose Luis Viramontes-Madrid; Alejandro Salcido-Montenegro; Neri Alejandro Álvarez-Villalobos; Victoria González-Nava; José Gerardo González-González
Journal:  BMC Med Ethics       Date:  2019-01-08       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.